Çağrı Şakalar

Small and Medium Enterprises Development Organization — Turkey

Medicine · Health Sciences

13h-index648citations42works0.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Infection Control and Ventilation(7), COVID-19 impact on air quality(5), Urinary Bladder and Prostate Research(4), Bioactive Compounds and Antitumor Agents(4), Nigella sativa pharmacological applications(3)

Publications42 total

A Novel and Cost-Friendly Expression Method of Taq DNA Polymerase Using Milk Powder and Effective Utilization of The Enzyme in Diagnostic Kits
Journal of Apitherapy and Nature·2025Open Access
SFRP2 and RPRM as methylation based serum biomarkers for the detection of gastric cancer
Discover Oncology·2025Open Access
Production of novel peptide‐targeting antibodies for anti‐Müllerian hormone receptor 2 and induction of cytotoxicity in ovarian cancer cells
Scandinavian Journal of Immunology·2024· 1 cited
A Novel and Cost-Friendly Expression Method of Taq DNA Polymerase Using Milk Powder and Effective Utilization of the Enzyme in Diagnostic Kits
Research Square (Research Square)·2024Open Access
Thermal Inactivation of Aerosolized SARS-CoV-2
2024Open Access
Thermal Inactivation of Airborne SARS-CoV-2 by an Electric Fan Heater in Winter and Defining Conditions to Ensure That All the Air Passes Through the Fan
Journal of Thermal Science and Engineering Applications·2023
Thermal Inactivation of Airborne SARS-CoV-2 with Interior Space Heaters in Winter
2022· 1 cited
Thermal Inactivation of Airborne SARS-CoV-2 with Interior Space Heaters in Winter
2022Open Access
Inactivation of airborne SARS-CoV-2 by thyme volatile oil vapor phase
Journal of Virological Methods·2022· 12 citedOpen Access
Rapid thermal inactivation of aerosolized SARS-CoV-2
Journal of Virological Methods·2022· 13 citedOpen Access
Thermal Inactivation of Aerosolized SARS-CoV-2
2021Open Access
Clitocybe geotropa TÜRÜ MANTARDAN ELDE EDİLEN EKSTRAKTLARIN MDA-MB-231 HÜCRE HATTI ÜZERİNDEKİ SİTOTOKSİK AKTİVİTESİNİN İNCELENMESİ
2017
Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A
Anti-Cancer Agents in Medicinal Chemistry·2017· 6 cited
Thymoquinone confers higher cytotoxicity against triple negative breast cancer compared to estrogen receptor positive breast cancer through modulation of TNF receptor superfamily genes and P65 activity
European Journal of Cancer·2016
A novel peptide-specific monoclonal antibody with a potential use for immunotherapy recognizes AMHR2 expressed by ovarian cancer cells
European Journal of Cancer·2016· 1 cited
SAT0413 Genetic Aspect of Inter-Individual Variability in The Response To Non-Steroidal anti-inflammatory Drugs in Axial Spondyloarthritis
Annals of the Rheumatic Diseases·2016· 1 cited
The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer
Tumor Biology·2015· 72 cited
Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway?
Tumor Biology·2015· 15 cited
Myrtucommulone-A Induces both Extrinsic and Intrinsic Apoptotic Pathways in Cancer Cells
Journal of Biochemical and Molecular Toxicology·2015· 32 cited
Evaluation of two different adjuvants with immunogenic uroplakin 3A-derived peptide for their ability to evoke an immune response in mice
European Cytokine Network·2015· 13 cited
page 1 of 3Next →

Frequent Co-authors

Kenan İzgi(9), Cengiz Z. Altuntas(9), Vincent K. Tuohy(9), Halit Canatan(8), Firouz Daneshgari(6), Murat Canpolat(6), Serhat Bozkurt(6), Ahmet Yılmaz Çoban(6), Deniz Karaçaylı(6), Emre Toker(6), Banu İskender(5), Huriye Aksu(5), Salih Kuk(5), Sedat Sezen(4), Büşra Kurt(4), Mustafa Çakır(3), Ali Turan(3), Fuat Bicer(3), Ahmet Özer(3), Esra Gürbüz(3)